AWARDDELIVERY ORDEROther than small business
Delivery order 75F40119F19005INFLEXXION, INC.
Overview
Award facts
- Net obligations
- $1.10M
- $1,095,103of $1.10M potential value
- Outlays (paid to date)
- $451.48K
- $451.48K paid of $1.10M obligated$451,478
- Period of performance
- Sep 12, 2019 to Jul 1, 2021
- Ended
- Modifications
- 1
- Latest action Jun 30, 2020
- Contract type
- Delivery order
- PIID 75F40119F19005
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
"IMPROVING THE QUALITY AND REPRESENTATIVENESS OF THE ADDICTION SEVERITY INDEX-MULTIMEDIA VERSION (ASI-MV) NETWORK"
Dates and value
- Award date
- Signed on Sep 12, 2019
- Potential end of performance
- Jun 30, 2021
- Current value
- $1,095,103Base and exercised options
- Potential value (if all options are exercised)
- $1,095,103
- Parent contract vehicle
- HHSF223201610027I (IDC, multiple award) — 5 orders recorded under it
Obligations by fiscal year of action
- FY2019: $1,095,103
Total across 1 fiscal year: $1,095,103
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 30, 2020. View on USAspending · Recipient on SAM.gov
Recipient
NameINFLEXXION, INC.
LocationNEWTON, MA
UEIMCFEKKLL1GT7
CAGE code3DNU6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyINFLEXXION, INC.
Business types and certifications
Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)
Self-reported at the time of the action.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded by
- Department of Health and Human Services
- Food And Drug Administration
- FDA OFFICE OF ACQ GRANT SVCS
- Funded from
- Human drugsProgram activities075-0600Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Newton Upper Falls, Middlesex County, Massachusetts 02464-1592
- Congressional district (place of performance)
- MA-04As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- B537SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH (service)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Subject to multiple award fair opportunityMAFO
- Set-aside
- Not reported
- Contract pricing
- Firm fixed priceJ
- Offers received
- 2
Solicitation and notices
- Solicitation ID
- FDARFP1168334(as reported)
- Solicitation date
- Aug 6, 2019
Contract details
- Subcontracting plan
- Plan not included - no subcontracting possibilitiesA
- Major program
- Data resource for post-marketing prescription and over-the-counter drug abuse surveillance data from
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial itemA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Transaction history
Modification history
- Base award
- Sep 12, 2019Base obligation at award: $1,095,103
- Latest action
- Jun 30, 2020 — Other administrative actionModification P00001; administrative: no change in scope or value
- Actions by type
- Base award1
- Other administrative action1
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Multiple awardM
- Parent vehicle agency
- Food And Drug Administration7524
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7524
- Contracting office code
- 75F401
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7524
- Funding office code
- 75F401
- Treasury accounts
- 075-2019/2019-0600-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression